On March 17, Baltimore’s early-stage biotech community gathered for an informal but meaningful milestone: the opening of the Blackbird BioHub and the three-year anniversary of Blackbird Laboratories. What began as a venture-backed initiative focused on funding bold scientific ideas in Baltimore has quickly evolved into a growing platform for company creation, early-stage capital, and now physical infrastructure designed to bring the region’s innovators together.

The event—equal parts celebration, networking session, and ecosystem showcase—brought together startup founders, investors, university partners, and regional stakeholders to mark the next phase of Blackbird’s effort to help scale Baltimore’s biotech ecosystem.

Speaking to the crowd gathered inside the newly opened space, Blackbird Laboratories co-founder Matt Tremblay reflected on how quickly the organization has grown since its launch three years ago.

“We’ve deployed $70 million in the first three years,” Tremblay said, noting that roughly half of that capital has supported research grants and collaborative projects, while the remainder has gone into investments across the firm’s portfolio companies.

That investment strategy has produced a growing pipeline of startups. According to Tremblay, Blackbird has backed 18 companies to date, with approximately 75% located in Baltimore and about 95% based in Maryland.

Beyond investing, the group has also been incubating new ventures directly from early-stage scientific concepts. Blackbird has funded 20 exploratory research projects so far, four of which have already matured into licensed intellectual property and new company formations.

The new BioHub now provides the physical environment to support that company-building pipeline.

The Blackbird BioHub spans roughly 35,000 square feet and includes shared laboratory facilities, private lab suites, office space, and open bench areas designed for startups at different stages of development.

But the design goes beyond traditional incubator space.

The facility features a bright, open layout intended to encourage interaction between teams, along with communal gathering areas—including an upper balcony overlooking the main floor—that can host town halls, fireside chats, and ecosystem events. Skylights and open architecture give the space an inviting atmosphere that mirrors the collaborative ethos Blackbird is trying to cultivate.

Tours throughout the event highlighted the flow of the space—from shared research benches to meeting rooms and private labs—while reinforcing its role as a central gathering point for Baltimore’s growing startup community.

Strategically located within the City Garage innovation district, the BioHub connects directly to the city garage infrastructure near Quest Diagnostics and sits close to LaunchPort and other medtech and biotech startups clustered in the surrounding ecosystem.

One of the BioHub’s most distinctive features is infrastructure that many early-stage biotech companies typically struggle to access.

A newly built vivarium operated by Myologica sits just across the hallway from the lab space, providing on-site animal research capabilities. For young companies operating on tight budgets, access to preclinical infrastructure locally can significantly reduce costs and development timelines.

Ramzi Khairallah, co-founder of Myologica, said the decision to build the vivarium was driven in part by a regional gap.

“There’s not a lot of animal support out in the region around here,” he said, explaining that many Maryland startups have historically had to outsource studies to service providers in Boston or the Bay Area.

By bringing those capabilities closer to home, the team hopes to keep more research activity—and funding—within the state.

“We want to help the other biotechs that are also bootstrapped… run extremely cost-effective studies to advance their programs,” Khairallah said.

The facility also includes a CLIA-certified laboratory environment intended to support early-stage diagnostic development, further broadening the types of companies the BioHub can support.

Where Infrastructure Meets Ecosystem

The BioHub is also part of a larger ecosystem taking shape inside City Garage—one that now represents one of Maryland’s most concentrated life science innovation clusters.

The campus brings together infrastructure, services, and capital in a way that allows early-stage companies to move from concept to commercialization without leaving the building.

Startups at City Garage can access lab space, LaunchPort’s medtech acceleration platform and contract manufacturing through on-site cleanroom facilities. The addition of Blackbird BioHub expands that offering further, particularly for therapeutics startups that need early-stage research infrastructure and access to capital.

Beyond infrastructure, the ecosystem also includes a growing network of vendors and service providers located on-site. RPM Tech supports device prototyping and engineering, while companies such as Workforce Genetics provide talent solutions tailored to life sciences companies and startups. BioBuzz, supports ecosystem programming as well as marketing, communications, and industry media coverage for companies building their presence.

Access to capital is also embedded in the campus. City Garage is now home to three venture firms: PTX Capital, led by Matt Hellauer; Ecphora Capital, led by Deb Hemingway, PhD; and Blackbird BioVentures, the organization behind the BioHub.

Together, these elements are beginning to form a rare end-to-end startup environment for life science companies—supporting everything from early research and prototyping to talent recruitment, manufacturing, and venture funding.

The event also featured short presentations from several companies and initiatives already taking root inside the BioHub.

Among them was EPOCH Epigenetics, a diagnostics company emerging from work previously developed within DARPA. Founder Eric Van Gieson described the company’s approach to disease detection, which focuses on analyzing epigenetic changes in immune cells rather than searching directly for tumor DNA fragments in the bloodstream.

Also presenting was Alitira Therapeutics, a gene therapy startup spun out of research at Johns Hopkins University. The company is developing technology designed to control when therapeutic genes are expressed—an approach aimed at improving both safety and efficacy in next-generation gene therapies.

The event also highlighted the upcoming National Center to Accelerate Cures initiative, which will be seeded with a $3 million federal grant and based within the BioHub. The center aims to advance alternative methods for drug development and testing, addressing the well-documented challenge that roughly 90% of drugs fail during clinical trials.

Together, these early residents reflect the broader ambition behind the space: creating a hub where scientific discovery, venture capital, and operational infrastructure intersect.

Why It Matters for Baltimore’s Biotech Ecosystem

Baltimore has long had world-class research institutions—including Johns Hopkins University, the University of Maryland, and multiple federal laboratories—but translating that research into venture-backed companies has historically lagged behind other biotech hubs.

Blackbird’s strategy aims to address that gap by focusing on three interconnected levers: early-stage capital, company creation, and now physical infrastructure.

Just as important, the BioHub was designed to be open to the broader community.

“It’s important to note that if you’re affiliated with Blackbird or you’re not, we would welcome you into this community,” Tremblay told attendees.

The Blackbird BioHub also builds on a broader wave of innovation infrastructure emerging across Baltimore. Just last year, the 4MLK building officially opened at the University of Maryland BioPark — a new 250,000-square-foot, $180 million life sciences tower. The eight-story facility was designed to serve as a major anchor for biotech growth in West Baltimore, bringing together startups, academic researchers, and established life science companies under one roof to accelerate collaboration and commercialization.

4MLK includes Connect Labs by Wexford, a flexible incubator platform that provides fully furnished laboratory space for early-stage companies alongside larger customizable lab and office suites for scaling organizations. The model reflects a growing recognition across the industry: thriving biotech ecosystems require a full spectrum of infrastructure—from incubators and venture creation platforms to shared research facilities and community spaces.

Together, developments like 4MLK, Connect Labs, and now the Blackbird BioHub are helping redefine Baltimore’s life science landscape. For founders looking to launch the next generation of biotech companies, that growing infrastructure may be one of Baltimore’s most important competitive advantages.

Three years after launching, Blackbird has already deployed tens of millions of dollars, supported dozens of research projects, and helped launch multiple companies. The BioHub now adds something equally important: a place where those ideas, companies, and collaborators can physically come together.

Inside City Garage, that convergence is becoming increasingly visible. Infrastructure, venture capital, startup talent, and research capability are now beginning to sit side by side—creating an environment where the next generation of Maryland life science companies can start, grow, and stay rooted in Baltimore.